Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Bulk RNA-seq of Cd40-deficient mice treated with neutralizing RANKL antibody

PROVIDER: PRJNA1152504 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR30398820_1.fastq.gz	Fastqsanger.gz
	SRR30398820_2.fastq.gz	Fastqsanger.gz
	SRR30398821_1.fastq.gz	Fastqsanger.gz
	SRR30398821_2.fastq.gz	Fastqsanger.gz
	SRR30398822_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 24

Similar Datasets

RNA-seq of diaphyseal bone from sclerostin-neutralizing antibody treated mice

Project description:RNA-seq of diaphyseal bone from sclerostin-neutralizing antibody treated mice

| PRJEB33292 | ENA

Next Generation Sequencing identifies lymph node lymphatic endothelial cell genes regulated by RANKL

Project description:Purpose: The objective was to identify genes regulted by RANK signalling in lymph node lymphatic endothelial cells Method: Lymphatic endothelial cells were FACS sorted from peripheral lymph nodes of mice deficient for stromal RANKL (Ccl19 Cre Rankl flox/flox) versus littermate controls (Rankl flox/flox) and processed for bulk RNA sequencing Results: Upregulated and downregulated genes were identified

2019-06-01 | GSE129315 | GEO

Inguinal LN cDC1 SubQ KPC

Project description:Bulk RNA sequencing of sorted inguinal LN cDC1s from healthy mice and mice subcutaneously implanted with KPC tumor both untreated and treated with CD40 agonist.

2020-04-15 | GSE126357 | GEO

Inguinal LN CD11c SubQ KPC

Project description:Bulk RNA sequencing of sorted inguinal LN CD11c+ cells from healthy mice and mice subcutaneously implanted with KPC tumor both untreated and treated with CD40 agonist.

2020-04-15 | GSE126356 | GEO

E-MTAB-8113

Project description:RNA-seq of diaphyseal bone from sclerostin-neutralizing antibody treated mice

2019-09-09 | E-MTAB-8113 | ExpressionAtlas

NOTCH2 Promotes Osteoclast Maturation and Metabolism and Modulates the Transcriptome Profile During Osteoclastogenesis

Project description:Bone marrow derived macrophages (BMM) from Notch2tm1.1Ecan, harboring a NOTCH2 gain-of-function mutation, and control mice were cultured with macrophage colony stimulating factor (M-CSF) and receptor activator of NF-kB ligand (RANKL). Bulk RNA-Seq revealed enhanced cell metabolism, aerobic respiration, and mitochondrial function, all associated with osteoclastogenesis, in Notch2tm1.1Ecan cells. Single cell RNA-Seq data of BMMs treated with M-CSF or M-CSF and RANKL for 3 days identified 11 well-defined cellular clusters. There was an increased number of cells expressing gene markers associated with the osteoclast and with related clusters in Notch2tm1.1Ecan than in control BMMs.

2024-01-03 | GSE248138 | GEO

NOTCH2 Promotes Osteoclast Maturation and Metabolism and Modulates the Transcriptome Profile During Osteoclastogenesis

2024-01-03 | GSE248137 | GEO

Expression data from OMP52M51 resistant or acute treated leukemic mice

Project description:We recently demonstrated that a human Notch1-specific neutralizing antibody (OMP52M51) was very effective in T-ALL patient derived xenografts (PDX) bearing NOTCH1/FBW7 mutations. However, we observed development of acquired resistance following long-term administration of the antibody and used PDX models to investigate this phenomenon. We analyzed expression profiles to identify genes and pathways modulated in mice treated until progression or acute treated with a neutralizing antibody against Notch1.

2020-05-20 | GSE123751 | GEO

RNA-seq of RANKL treated mouse intestinal organoids

Project description:We generated intestinal organoids from a C57BL6/J mouse and stimulated them with mouse recombinant RANKL. We generated bulk RNA-seq data from them.

2024-09-07 | GSE225511 | GEO

Next Generation Sequencing of endothelial cells (HUVECs) after treatment by conditioned media obtained from gastric cancer anoikis resistant(GCAR) cells in the presence or absence of neutralizing antibody against PDGFB

Project description:To identify the dominant signaling events downstream of GCAR-derived PDGFB in HUVECs，we performed RNA sequencing (RNA-seq) in HUVECs treated by conditioned media obtained from GCAR cells in the presence or absence of neutralizing antibody against PDGFB. The RNA-seq data shows that GCAR cells derived PDGFB may promote angiogenesis through MAPK/ERK signaling pathway.

2021-06-10 | GSE176441 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data